Skip to main content

IBM Research - Nanomedicine

[an error occurred while processing this directive]

IBM - Almaden Nanomedicine

ew bacteria-fighting polymers, about 500,000 times small than the width of a human hair, penetrate the membranes of antibiotic-resistant bacteria cells, killing them from the inside out and then disappearing - without ever harming healthy red blood cells

IBM - Almaden Nanomedicine

Researchers from IBM and the Institute for Bioengineering and Nanotechnology published a nanomedicine breakthrough in Nature Chemistry, demonstrating the first biodegradable antimicrobial polymer nanoparticles to combat drug-resistant bacteria and infectious diseases like Methicillin-resistant Staphylococcus aureus, known as MRSA. Unlike conventional antibiotics, these nanostructures target infected cells without destroying healthy red blood cells. Read the IBM Press Release.

IBM lead researcher on the nanomedicine breakthrough, James Hedrick, in the chemistry lab at IBM Research - Almaden. Team members Kazuki Fukushima, Dan Coady, James Hedrick and Amanda Engler in the chemistry lab.James Hedrick interviewing with ABC 7 KGO-TV reporter Karina Rusk.

IBM Research - Almaden Nanomedicine News

[an error occurred while processing this directive] [an error occurred while processing this directive] [an error occurred while processing this directive]